Sanofi SA (SNY) CEO Paul Hudson on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/28/22
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1GlobeNewsWire • 04/28/22
Press Release: Sanofi teams up with McLaren Racing to accelerate industrial excellenceGlobeNewsWire • 04/26/22
Sempre Health Improved Medication Adherence by 25% for Diabetes Patients Prescribed Sanofi MedicationsPRNewsWire • 04/13/22
Regeneron (REGN), Sanofi's Dupixent Gets EU Nod for Asthma in KidsZacks Investment Research • 04/07/22
Press Release: Sanofi launches first-in-pharma Diversity, Equity & Inclusion BoardGlobeNewsWire • 04/04/22
Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicinesGlobeNewsWire • 03/31/22